Related Experiment Videos
Fast fraction haemoglobin (HbA1) in the assessment of diabetes control
Insights
Assessing diabetes control requires more than just symptoms or fasting blood glucose. Hemoglobin A1c (HbA1c) provides a more accurate measure of long-term glycemic control in diabetic patients.
Area of Science:
- Endocrinology and Metabolism
- Clinical Diagnostics
Background:
- Effective management of diabetes mellitus relies on accurate assessment of glycemic control.
- Traditional methods like symptom monitoring and casual blood glucose tests may not fully reflect long-term metabolic status.
Purpose of the Study:
- To evaluate the reliability of various clinical parameters in assessing glycemic control in diabetic patients.
- To compare these assessments against Hemoglobin A1c (HbA1c) as the gold standard for long-term glycemic control.
Main Methods:
- Assessed glycemic control in 132 diabetic patients using historical data, urine glucose, and blood glucose measurements.
- Correlated these measures with Hemoglobin A1c (HbA1c) levels.
- Analyzed the sensitivity and specificity of symptoms of hyperglycemia and glycosuria.
Main Results:
- Symptoms of hyperglycemia and glycosuria were neither sensitive nor specific indicators of glycemic control.
- Fasting blood glucose showed only a modest correlation with HbA1c, leading to potential over- or under-assessment in 30% of patients.
- Timed post-breakfast blood glucose measurements (120 and 150 minutes) demonstrated strong correlations with HbA1c.
Conclusions:
- Clinical impressions based on combined historical data, urine, and casual blood glucose measurements resulted in undertreatment (41%) and overtreatment (27%).
- Hemoglobin A1c (HbA1c) is crucial for accurate assessment of long-term glycemic control.
- Timed post-breakfast blood glucose measurements offer valuable supplementary data for assessing diabetes management.
Abstract:
The degree of control of 132 diabetic patients was assessed using historical data, urine glucose and blood glucose measurements. These were then related to HbA1, taken as the final arbiter of glycaemic control. Symptoms of hyperglycaemia and glycosuria were found to be not sensitive or specific indices of control, though symptomatic glycosuric patients tended to have higher HbA1. Fasting blood glucose correlated modestly with HbA1 (r = 0.60, p less than 0.001) but if used alone to determine degree of control, 21% and 9% of patients could be expected to be over or under assessed respectively. The assessment value of timed post-breakfast blood glucose applied only to 120 and 150 minutes post-breakfast blood glucose as they correlated well with HbA1 (r = 0.73, p less than 0.001 and r = 0.96, p less than 0.001 respectively). Clinically impression of degree of control based on a combination of historical data, urine glucose and blood glucose led to "undertreatment" in 41% and "overtreatment" in 27% of patients. The complementary value of a knowledge of HbA1 was thus highlighted.